The 17th International Winter Eicosanoid Conference
Eicosanoid Research Association, Inc.









We gratefully acknowledge the following Institutions for their support


of the 17th International Winter Eicosanoid Conference.


 


SPONSORS



            






Image result for cayman chemical company

www.caymanchem.com






 










www.corbuspharma.com

Corbus Pharmaceuticals Holdings, Inc. is a development stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company’s lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.





Home

www.detroitrandd.com




 

Elsevier wordmark


Prostaglandins and Other Lipid Mediators

https://www.journals.elsevier.com/prostaglandins-and-other-lipid-mediators/



 


Lipidomix - Expert in Lipid Analytics

www.lipidomix.de





d

Inception Sciences


www.inceptionsci.com

 



National Institute of Environmental Health Sciences




OMEICOS Therapeutics GmbH




Pharmacology

New York Medical College





                           




March 11-13,2018

Baltimore, Maryland

Corbus_Pharma_Logo.jpg